After 25 years of drug development, do we know JAK?
Crossref DOI link: https://doi.org/10.1136/rmdopen-2022-002409
Published Online: 2022-07-13
Published Print: 2022-07
Update policy: https://doi.org/10.1136/crossmarkpolicy
Mortezavi, Mahta
Martin, David A
Schulze-Koops, Hendrik https://orcid.org/0000-0002-1681-491X
Funding for this research was provided by:
Pfizer
License valid from 2022-07-13